Prescriber perceptions of the safety and efficacy of unfractionated heparin versus low molecular weight heparin in the acute treatment phase: a qualitative study
Future interventions should focus on highlighting LMWH as the preferred heparinoid in most clinical scenarios. The use of IVUFH should be reserved for specific patient cohorts where the benefit of IVUFH outweighs the additional risks.
Authors
- Catherine Edmunds (ORCID: https://orcid.org/0009-0007-5889-1968)
- Indu Singh (ORCID: https://orcid.org/0000-0002-0498-4209)
- Roselyn B. Rose’Meyer (ORCID: https://orcid.org/0000-0003-3677-0608)
- Laetitia Hattingh (ORCID: https://orcid.org/0000-0002-4553-743X)
- Danielle Green (ORCID: https://orcid.org/0009-0000-7379-8525)
Institutions
- Griffith University (AU)
- The University of Queensland (AU)
- Gold Coast Hospital (AU)
- Gold Coast Health (AU)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1080/20523211.2024.2418367
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Griffith University